Trenbolone hexahydrobenzylcarbonate

Trenbolone hexahydrobenzylcarbonate
Clinical data

Trade names	Parabolan, Hexabolan
Routes of administration	Intramuscular injection
Identifiers
IUPAC name Cyclohexylmethyl [(8S,13S,14S,17S)-13-methyl-3-oxo-2,6,7,8,14,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl] carbonate
CAS Number	23454-33-3
PubChem CID	20055297
ChemSpider	16736552
UNII	BNJ7Y3JFF2
Chemical and physical data
Formula	C₂₆H₃₄O₄
Molar mass	410.554 g/mol
3D model (Jmol)	Interactive image
SMILES C[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@H]2OC(=O)OCC5CCCCC5
InChI InChI=1S/C26H34O4/c1-26-14-13-21-20-10-8-19(27)15-18(20)7-9-22(21)23(26)11-12-24(26)30-25(28)29-16-17-5-3-2-4-6-17/h13-15,17,22-24H,2-12,16H2,1H3/t22-,23+,24+,26+/m1/s1 Key:GQJSFWYQKNQCIK-APFRJGHOSA-N

Trenbolone hexahydrobenzylcarbonate (brand name Parabolan, Hexabolan), or trenbolone cyclohexylmethylcarbonate, also known as estra-4,9,11-trien-17β-ol-3-one 17β-cyclohexylmethylcarbonate, is a synthetic anabolic-androgenic steroid (AAS) of the 19-nortestosterone group and an androgen ester – specifically, the 17β-hexahydrobenzylcarbonate ester of trenbolone – which was marketed in France for human clinical use but has since been discontinued. It was introduced in France in 1980 and voluntarily discontinued by its manufacturer in 1997. It acts as a long-acting prodrug of trenbolone when administered via intramuscular injection.

...
Wikipedia